Tiotropium Bromide/BI-54903

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTiotropium Bromide/BI-54903

Drug Alias Name噻托溴铵/BI-54903BI-54903 and Tiotropium BromideBI-54903/Tiotropium BromideTiotropium Bromide and BI-54903Tiotropium Bromide Hydrate/BI-54903

ClassificationSmall molecules

Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonistsGlucocorticoid receptor agonists

TargetsGlucocorticoid receptorMuscarinic acetylcholine receptor M3

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Tiotropium Bromide BI-54903

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesC.H. Boehringer Sohn Ag & Co. Kg

Active IndicationsN/A

Inactive IndicationsAsthma

Other Information

ATC CodeN/A